{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:22:58Z","timestamp":1778642578148,"version":"3.51.4"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T00:00:00Z","timestamp":1595548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T00:00:00Z","timestamp":1595548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"publisher","award":["Australian Government Research Training Program Scholarship"],"award-info":[{"award-number":["Australian Government Research Training Program Scholarship"]}],"id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s12265-020-10062-z","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T20:03:39Z","timestamp":1595621019000},"page":"327-337","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Impact of Targeted Therapies for Coronary Microvascular Dysfunction as Assessed by the Index of Microcirculatory Resistance"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1782-5001","authenticated-orcid":false,"given":"James","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidney","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig P.","family":"Juergens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic Y.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,24]]},"reference":[{"issue":"5","key":"10062_CR1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/01.mca.0000134590.99841.81","volume":"15","author":"MB Britten","year":"2004","unstructured":"Britten, M. B., Zeiher, A. M., & Schachinger, V. (2004). Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome. Coronary Artery Disease, 15(5), 259\u2013264.","journal-title":"Coronary Artery Disease"},{"issue":"25","key":"10062_CR2","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.jacc.2010.01.054","volume":"55","author":"CJ Pepine","year":"2010","unstructured":"Pepine, C. J., Anderson, R. D., Sharaf, B. L., Reis, S. E., Smith, K. M., Handberg, E. M., et al. (2010). Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia. Journal of the American College of Cardiology, 55(25), 2825\u20132832.","journal-title":"Journal of the American College of Cardiology"},{"issue":"11","key":"10062_CR3","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jcin.2015.06.017","volume":"8","author":"JD Sara","year":"2015","unstructured":"Sara, J. D., Widmer, R. J., Matsuzawa, Y., Lennon, R. J., Lerman, L. O., & Lerman, A. (2015). Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease. JACC. Cardiovascular Interventions, 8(11), 1445\u20131453.","journal-title":"JACC. Cardiovascular Interventions"},{"issue":"2","key":"10062_CR4","first-page":"210","volume":"8","author":"MA Marinescu","year":"2015","unstructured":"Marinescu, M. A., Loffler, A. I., Ouellette, M., Smith, L., Kramer, C. M., & Bourque, J. M. (2015). Coronary microvascular dysfunction, microvascular angina, and treatment strategies. JACC: Cardiovascular Imaging, 8(2), 210\u2013220.","journal-title":"JACC: Cardiovascular Imaging"},{"issue":"20","key":"10062_CR5","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1136\/heartjnl-2012-302252","volume":"98","author":"JJ Layland","year":"2012","unstructured":"Layland, J. J., Whitbourn, R. J., Burns, A. T., Somaratne, J., Leitl, G., Macisaac, A. I., et al. (2012). The index of microvascular resistance identifies patients with periprocedural myocardial infarction in elective percutaneous coronary intervention. Heart., 98(20), 1492\u20131497.","journal-title":"Heart."},{"issue":"4","key":"10062_CR6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/CIRCINTERVENTIONS.112.969048","volume":"5","author":"MK Ng","year":"2012","unstructured":"Ng, M. K., Yong, A. S., Ho, M., Shah, M. G., Chawantanpipat, C., O'Connell, R., et al. (2012). The index of microcirculatory resistance predicts myocardial infarction related to percutaneous coronary intervention. Circulation. Cardiovascular Interventions, 5(4), 515\u2013522.","journal-title":"Circulation. Cardiovascular Interventions"},{"issue":"5","key":"10062_CR7","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jacc.2007.08.062","volume":"51","author":"WF Fearon","year":"2008","unstructured":"Fearon, W. F., Shah, M., Ng, M., Brinton, T., Wilson, A., Tremmel, J. A., et al. (2008). Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction. Journal of the American College of Cardiology, 51(5), 560\u2013565.","journal-title":"Journal of the American College of Cardiology"},{"issue":"23","key":"10062_CR8","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1093\/eurheartj\/ehp313","volume":"30","author":"HS Lim","year":"2009","unstructured":"Lim, H. S., Yoon, M. H., Tahk, S. J., Yang, H. M., Choi, B. J., Choi, S. Y., et al. (2009). Usefulness of the index of microcirculatory resistance for invasively assessing myocardial viability immediately after primary angioplasty for anterior myocardial infarction. European Heart Journal, 30(23), 2854\u20132860.","journal-title":"European Heart Journal"},{"issue":"24","key":"10062_CR9","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1161\/CIRCULATIONAHA.112.000298","volume":"127","author":"WF Fearon","year":"2013","unstructured":"Fearon, W. F., Low, A. F., Yong, A. S., McGeoch, R., Berry, C., Shah, M. G., et al. (2013). Prognostic value of the index of microcirculatory resistance measured after primary percutaneous coronary intervention. Circulation., 127(24), 2436\u20132441.","journal-title":"Circulation."},{"key":"10062_CR10","first-page":"1","volume":"00","author":"T Murai","year":"2018","unstructured":"Murai, T., Yonetsu, T., Kanaji, Y., Usui, E., Hoshino, M., Hada, M., et al. (2018). Prognostic value of the index of microcirculatory resistance after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome. Catheterization and Cardiovascular Interventions, 00, 1\u201312.","journal-title":"Catheterization and Cardiovascular Interventions"},{"issue":"25","key":"10062_CR11","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1161\/01.CIR.0000080700.98607.D1","volume":"107","author":"WF Fearon","year":"2003","unstructured":"Fearon, W. F., Balsam, L. B., Farouque, H. M., Caffarelli, A. D., Robbins, R. C., Fitzgerald, P. J., et al. (2003). Novel index for invasively assessing the coronary microcirculation. Circulation., 107(25), 3129\u20133132.","journal-title":"Circulation."},{"issue":"17","key":"10062_CR12","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/CIRCULATIONAHA.105.603522","volume":"113","author":"MK Ng","year":"2006","unstructured":"Ng, M. K., Yeung, A. C., & Fearon, W. F. (2006). Invasive assessment of the coronary microcirculation: Superior reproducibility and less hemodynamic dependence of index of microcirculatory resistance compared with coronary flow reserve. Circulation., 113(17), 2054\u20132061.","journal-title":"Circulation."},{"issue":"15","key":"10062_CR13","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1161\/01.CIR.0000143893.18451.0E","volume":"110","author":"W Aarnoudse","year":"2004","unstructured":"Aarnoudse, W., Fearon, W. F., Manoharan, G., Geven, M., van de Vosse, F., Rutten, M., et al. (2004). Epicardial stenosis severity does not affect minimal microcirculatory resistance. Circulation., 110(15), 2137\u20132142.","journal-title":"Circulation."},{"issue":"3","key":"10062_CR14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"J Knuuti","year":"2020","unstructured":"Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., et al. (2020). 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal, 41(3), 407\u2013477.","journal-title":"European Heart Journal"},{"issue":"1","key":"10062_CR15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.hlc.2019.05.187","volume":"29","author":"J Xu","year":"2020","unstructured":"Xu, J., Lo, S., Juergens, C. P., & Leung, D. Y. (2020). Assessing coronary microvascular dysfunction in Ischaemic heart disease: Little things can make a big difference. Heart, Lung & Circulation, 29(1), 118\u2013127.","journal-title":"Heart, Lung & Circulation"},{"issue":"19","key":"10062_CR16","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1161\/01.CIR.0000128669.99355.CB","volume":"109","author":"WF Fearon","year":"2004","unstructured":"Fearon, W. F., Aarnoudse, W., Pijls, N. H., De Bruyne, B., Balsam, L. B., Cooke, D. T., et al. (2004). Microvascular resistance is not influenced by epicardial coronary artery stenosis severity: Experimental validation. Circulation., 109(19), 2269\u20132272.","journal-title":"Circulation."},{"issue":"1","key":"10062_CR17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jcin.2012.08.019","volume":"6","author":"AS Yong","year":"2013","unstructured":"Yong, A. S., Layland, J., Fearon, W. F., Ho, M., Shah, M. G., Daniels, D., et al. (2013). Calculation of the index of microcirculatory resistance without coronary wedge pressure measurement in the presence of epicardial stenosis. JACC. Cardiovascular Interventions, 6(1), 53\u201358.","journal-title":"JACC. Cardiovascular Interventions"},{"issue":"5","key":"10062_CR18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJMra0912134","volume":"364","author":"A Prasad","year":"2011","unstructured":"Prasad, A., & Herrmann, J. (2011). Myocardial infarction due to percutaneous coronary intervention. The New England Journal of Medicine, 364(5), 453\u2013464.","journal-title":"The New England Journal of Medicine"},{"issue":"20","key":"10062_CR19","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.ehj.2004.07.017","volume":"25","author":"C Briguori","year":"2004","unstructured":"Briguori, C., Colombo, A., Airoldi, F., Violante, A., Focaccio, A., Balestrieri, P., et al. (2004). Statin administration before percutaneous coronary intervention: Impact on periprocedural myocardial infarction. European Heart Journal, 25(20), 1822\u20131828.","journal-title":"European Heart Journal"},{"issue":"6","key":"10062_CR20","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/01.CIR.0000137828.06205.87","volume":"110","author":"V Pasceri","year":"2004","unstructured":"Pasceri, V., Patti, G., Nusca, A., Pristipino, C., Richichi, G., Di Sciascio, G., et al. (2004). Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: Results from the ARMYDA (atorvastatin for reduction of MYocardial damage during angioplasty) study. Circulation., 110(6), 674\u2013678.","journal-title":"Circulation."},{"issue":"12","key":"10062_CR21","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jacc.2007.02.025","volume":"49","author":"G Patti","year":"2007","unstructured":"Patti, G., Pasceri, V., Colonna, G., Miglionico, M., Fischetti, D., Sardella, G., et al. (2007). Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: Results of the ARMYDA-ACS randomized trial. Journal of the American College of Cardiology, 49(12), 1272\u20131278.","journal-title":"Journal of the American College of Cardiology"},{"issue":"5","key":"10062_CR22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jcin.2011.02.005","volume":"4","author":"K Fujii","year":"2011","unstructured":"Fujii, K., Kawasaki, D., Oka, K., Akahori, H., Iwasaku, T., Fukunaga, M., et al. (2011). The impact of pravastatin pre-treatment on periprocedural microcirculatory damage in patients undergoing percutaneous coronary intervention. JACC. Cardiovascular Interventions, 4(5), 513\u2013520.","journal-title":"JACC. Cardiovascular Interventions"},{"issue":"4","key":"10062_CR23","first-page":"355","volume":"10","author":"GX He","year":"2013","unstructured":"He, G. X., & Tan, W. (2013). High-dose atorvastatin pretreatment could diminishes microvascular impairment in patients undergoing elective percutaneous coronary intervention. Journal of Geriatric Cardiology, 10(4), 355\u2013360.","journal-title":"Journal of Geriatric Cardiology"},{"issue":"4","key":"10062_CR24","doi-asserted-by":"crossref","first-page":"472","DOI":"10.4070\/kcj.2016.46.4.472","volume":"46","author":"BK Lee","year":"2016","unstructured":"Lee, B. K., Koo, B. K., Nam, C. W., Doh, J. H., Chung, W. Y., Cho, B. R., et al. (2016). Does pre-treatment with high dose atorvastatin prevent microvascular dysfunction after percutaneous coronary intervention in patients with acute coronary syndrome? Korean Circualtion Journal., 46(4), 472\u2013480.","journal-title":"Korean Circualtion Journal."},{"issue":"5","key":"10062_CR25","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/ccd.28157","volume":"94","author":"OG Solberg","year":"2019","unstructured":"Solberg, O. G., Stavem, K., Ragnarsson, A., Beitnes, J. O., Skardal, R., Seljeflot, I., et al. (2019). Index of microvascular resistance to assess the effect of rosuvastatin on microvascular function in women with chest pain and no obstructive coronary artery disease: A double-blind randomized study. Catheterization and Cardiovascular Interventions, 94(5), 660\u2013668.","journal-title":"Catheterization and Cardiovascular Interventions"},{"issue":"11","key":"10062_CR26","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., et al. (2009). Ticagrelor versus clopidogrel in patients with acute coronary syndromes. The New England Journal of Medicine, 361(11), 1045\u20131057.","journal-title":"The New England Journal of Medicine"},{"issue":"20","key":"10062_CR27","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"SD Wiviott","year":"2007","unstructured":"Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., et al. (2007). Prasugrel versus clopidogrel in patients with acute coronary syndromes. The New England Journal of Medicine, 357(20), 2001\u20132015.","journal-title":"The New England Journal of Medicine"},{"issue":"14","key":"10062_CR28","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa1300815","volume":"368","author":"DL Bhatt","year":"2013","unstructured":"Bhatt, D. L., Stone, G. W., Mahaffey, K. W., Gibson, C. M., Steg, P. G., Hamm, C. W., et al. (2013). Effect of platelet inhibition with cangrelor during PCI on ischemic events. The New England Journal of Medicine, 368(14), 1303\u20131313.","journal-title":"The New England Journal of Medicine"},{"issue":"23","key":"10062_CR29","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.jacc.2014.03.031","volume":"63","author":"M Cattaneo","year":"2014","unstructured":"Cattaneo, M., Schulz, R., & Nylander, S. (2014). Adenosine-mediated effects of ticagrelor: Evidence and potential clinical relevance. Journal of the American College of Cardiology, 63(23), 2503\u20132509.","journal-title":"Journal of the American College of Cardiology"},{"issue":"7","key":"10062_CR30","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jacc.2012.11.032","volume":"61","author":"A Wittfeldt","year":"2013","unstructured":"Wittfeldt, A., Emanuelsson, H., Brandrup-Wognsen, G., van Giezen, J. J., Jonasson, J., Nylander, S., et al. (2013). Ticagrelor enhances adenosine-induced coronary vasodilatory responses in humans. Journal of the American College of Cardiology, 61(7), 723\u2013727.","journal-title":"Journal of the American College of Cardiology"},{"issue":"8","key":"10062_CR31","doi-asserted-by":"crossref","first-page":"e964","DOI":"10.4244\/EIJV12I8A159","volume":"12","author":"SD Park","year":"2016","unstructured":"Park, S. D., Lee, M. J., Baek, Y. S., Kwon, S. W., Shin, S. H., Woo, S. I., et al. (2016). Randomised trial to compare a protective effect of clopidogrel versus TIcagrelor on coronary microvascular injury in ST-segment elevation myocardial infarction (CV-TIME trial). EuroIntervention., 12(8), e964\u2013ee71.","journal-title":"EuroIntervention."},{"issue":"7","key":"10062_CR32","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1055\/s-0039-1688789","volume":"119","author":"S Ubaid","year":"2019","unstructured":"Ubaid, S., Ford, T. J., Berry, C., Murray, H. M., Wrigley, B., Khan, N., et al. (2019). Cangrelor versus ticagrelor in patients treated with primary percutaneous coronary intervention: Impact on platelet activity, myocardial microvascular function and infarct size: A randomized controlled trial. Thrombosis and Haemostasis, 119(7), 1171\u20131181.","journal-title":"Thrombosis and Haemostasis"},{"issue":"5","key":"10062_CR33","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/CIRCULATIONAHA.118.035931","volume":"139","author":"MAH van Leeuwen","year":"2019","unstructured":"van Leeuwen, M. A. H., van der Hoeven, N. W., Janssens, G. N., Everaars, H., Nap, A., Lemkes, J. S., et al. (2019). Evaluation of microvascular injury in revascularized patients with ST-segment-elevation myocardial infarction treated with ticagrelor versus prasugrel. Circulation., 139(5), 636\u2013646.","journal-title":"Circulation."},{"issue":"2","key":"10062_CR34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jacc.2016.04.039","volume":"68","author":"F Mangiacapra","year":"2016","unstructured":"Mangiacapra, F., Di Gioia, G., Pellicano, M., Di Serafino, L., Bressi, E., Peace, A. J., et al. (2016). Effects of prasugrel versus clopidogrel on coronary microvascular function in patients undergoing elective PCI. Journal of the American College of Cardiology, 68(2), 235\u2013237.","journal-title":"Journal of the American College of Cardiology"},{"issue":"18","key":"10062_CR35","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMoa054374","volume":"356","author":"M Sezer","year":"2007","unstructured":"Sezer, M., Oflaz, H., Goren, T., Okcular, I., Umman, B., Nisanci, Y., et al. (2007). Intracoronary streptokinase after primary percutaneous coronary intervention. The New England Journal of Medicine, 356(18), 1823\u20131834.","journal-title":"The New England Journal of Medicine"},{"issue":"12","key":"10062_CR36","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.jacc.2009.04.083","volume":"54","author":"M Sezer","year":"2009","unstructured":"Sezer, M., Cimen, A., Aslanger, E., Elitok, A., Umman, B., Bugra, Z., et al. (2009). Effect of intracoronary streptokinase administered immediately after primary percutaneous coronary intervention on long-term left ventricular infarct size, volumes, and function. Journal of the American College of Cardiology, 54(12), 1065\u20131071.","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10062_CR37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.2018.19802","volume":"321","author":"PJ McCartney","year":"2019","unstructured":"McCartney, P. J., Eteiba, H., Maznyczka, A. M., McEntegart, M., Greenwood, J. P., Muir, D. F., et al. (2019). Effect of low-dose intracoronary alteplase during primary percutaneous coronary intervention on microvascular obstruction in patients with acute myocardial infarction: A randomized clinical trial. JAMA., 321(1), 56\u201368.","journal-title":"JAMA."},{"issue":"1","key":"10062_CR38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ccd.23109","volume":"79","author":"C Kirma","year":"2012","unstructured":"Kirma, C., Erkol, A., Pala, S., Oduncu, V., Dundar, C., Izgi, A., et al. (2012). Intracoronary bolus-only compared with intravenous bolus plus infusion of tirofiban application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Catheterization and Cardiovascular Interventions, 79(1), 59\u201367.","journal-title":"Catheterization and Cardiovascular Interventions"},{"key":"10062_CR39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijcard.2016.01.204","volume":"208","author":"Z Sun","year":"2016","unstructured":"Sun, Z., Zeng, J., & Huang, H. (2016). Intracoronary injection of tirofiban prevents microcirculation dysfunction during delayed percutaneous coronary intervention in patients with acute myocardial infarction. International Journal of Cardiology, 208, 137\u2013140.","journal-title":"International Journal of Cardiology"},{"issue":"21","key":"10062_CR40","doi-asserted-by":"crossref","first-page":"J18","DOI":"10.1016\/0002-9149(89)90200-2","volume":"63","author":"N Taira","year":"1989","unstructured":"Taira, N. (1989). Nicorandil as a hybrid between nitrates and potassium channel activators. The American Journal of Cardiology., 63(21), J18\u2013J24.","journal-title":"The American Journal of Cardiology."},{"issue":"3","key":"10062_CR41","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/FJC.0b013e318163a95f","volume":"51","author":"Y Ishibashi","year":"2008","unstructured":"Ishibashi, Y., Takahashi, N., Tokumaru, A., Karino, K., Sugamori, T., Sakane, T., et al. (2008). Effects of long-term nicorandil administration on endothelial function, inflammation, and oxidative stress in patients without coronary artery disease. Journal of Cardiovascular Pharmacology, 51(3), 311\u2013316.","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"9","key":"10062_CR42","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4244\/EIJV9I9A178","volume":"9","author":"A Hirohata","year":"2014","unstructured":"Hirohata, A., Yamamoto, K., Hirose, E., Kobayashi, Y., Takafuji, H., Sano, F., et al. (2014). Nicorandil prevents microvascular dysfunction resulting from PCI in patients with stable angina pectoris: A randomised study. EuroIntervention., 9(9), 1050\u20131056.","journal-title":"EuroIntervention."},{"key":"10062_CR43","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12947-015-0020-9","volume":"13","author":"J Kostic","year":"2015","unstructured":"Kostic, J., Djordjevic-Dikic, A., Dobric, M., Milasinovic, D., Nedeljkovic, M., Stojkovic, S., et al. (2015). The effects of nicorandil on microvascular function in patients with ST segment elevation myocardial infarction undergoing primary PCI. Cardiovascular Ultrasound, 13, 26.","journal-title":"Cardiovascular Ultrasound"},{"issue":"5","key":"10062_CR44","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1253\/circj.CJ-09-0943","volume":"74","author":"N Ito","year":"2010","unstructured":"Ito, N., Nanto, S., Doi, Y., Sawano, H., Masuda, D., Yamashita, S., et al. (2010). High index of microcirculatory resistance level after successful primary percutaneous coronary intervention can be improved by intracoronary administration of nicorandil. Circulation Journal, 74(5), 909\u2013915.","journal-title":"Circulation Journal"},{"issue":"5","key":"10062_CR45","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.4244\/EIJ-D-17-00307","volume":"13","author":"RJ van Geuns","year":"2017","unstructured":"van Geuns, R. J., Sideris, G., Van Royen, N., El Mahmoud, R., Diletti, R., Bal Dit Sollier, C., et al. (2017). Bivalirudin infusion to reduce ventricular infarction: The open-label, randomised bivalirudin infusion for ventricular infArction limitation (BIVAL) study. EuroIntervention., 13(5), e540\u2013e5e8.","journal-title":"EuroIntervention."},{"issue":"6","key":"10062_CR46","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1536\/ihj.53.337","volume":"53","author":"K Morimoto","year":"2012","unstructured":"Morimoto, K., Ito, S., Nakasuka, K., Sekimoto, S., Miyata, K., Inomata, M., et al. (2012). Acute effect of sodium nitroprusside on microvascular dysfunction in patients who underwent percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. International Heart Journal, 53(6), 337\u2013340.","journal-title":"International Heart Journal"},{"issue":"6","key":"10062_CR47","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jacc.2012.11.025","volume":"61","author":"F Mangiacapra","year":"2013","unstructured":"Mangiacapra, F., Peace, A. J., Di Serafino, L., Pyxaras, S. A., Bartunek, J., Wyffels, E., et al. (2013). Intracoronary enalaPrilat to reduce MICROvascular damage during percutaneous coronary intervention (ProMicro) study. Journal of the American College of Cardiology, 61(6), 615\u2013621.","journal-title":"Journal of the American College of Cardiology"},{"issue":"16","key":"10062_CR48","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1136\/heartjnl-2016-309642","volume":"102","author":"GL De Maria","year":"2016","unstructured":"De Maria, G. L., Kassimis, G., Raina, T., & Banning, A. P. (2016). Reconsidering the back door approach by targeting the coronary sinus in ischaemic heart disease. Heart., 102(16), 1263\u20131269.","journal-title":"Heart."},{"issue":"3","key":"10062_CR49","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.4244\/EIJ-D-18-00378","volume":"14","author":"GL De Maria","year":"2018","unstructured":"De Maria, G. L., Alkhalil, M., Borlotti, A., Wolfrum, M., Gaughran, L., Dall'Armellina, E., et al. (2018). Index of microcirculatory resistance-guided therapy with pressure-controlled intermittent coronary sinus occlusion improves coronary microvascular function and reduces infarct size in patients with ST-elevation myocardial infarction: The Oxford acute myocardial infarction - pressure-controlled intermittent coronary sinus occlusion study (OxAMI-PICSO study). EuroIntervention., 14(3), e352\u2013e359.","journal-title":"EuroIntervention."},{"issue":"14","key":"10062_CR50","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1053\/euhj.2001.3035","volume":"23","author":"JP Henriques","year":"2002","unstructured":"Henriques, J. P., Zijlstra, F., Ottervanger, J. P., de Boer, M. J., Van \u2018t Hof, A. W., Hoorntje, J. C., et al. (2002). Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. European Heart Journal, 23(14), 1112\u20131117.","journal-title":"European Heart Journal"},{"issue":"2","key":"10062_CR51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/CIRCULATIONAHA.116.025371","volume":"135","author":"SS Jolly","year":"2017","unstructured":"Jolly, S. S., James, S., Dzavik, V., Cairns, J. A., Mahmoud, K. D., Zijlstra, F., et al. (2017). Thrombus aspiration in ST-segment-elevation myocardial infarction: An individual patient meta-analysis: Thrombectomy trialists collaboration. Circulation., 135(2), 143\u2013152.","journal-title":"Circulation."},{"issue":"9","key":"10062_CR52","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4244\/EIJV9I9A179","volume":"9","author":"SI Woo","year":"2014","unstructured":"Woo, S. I., Park, S. D., Kim, D. H., Kwan, J., Shin, S. H., Park, K. S., et al. (2014). Thrombus aspiration during primary percutaneous coronary intervention for preserving the index of microcirculatory resistance: A randomised study. EuroIntervention., 9(9), 1057\u20131062.","journal-title":"EuroIntervention."},{"issue":"3","key":"10062_CR53","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3349\/ymj.2014.55.3.606","volume":"55","author":"SG Ahn","year":"2014","unstructured":"Ahn, S. G., Lee, S. H., Lee, J. H., Lee, J. W., Youn, Y. J., Ahn, M. S., et al. (2014). Efficacy of combination treatment with intracoronary abciximab and aspiration thrombectomy on myocardial perfusion in patients with ST-segment elevation myocardial infarction undergoing primary coronary stenting. Yonsei Medical Journal, 55(3), 606\u2013616.","journal-title":"Yonsei Medical Journal"},{"issue":"1","key":"10062_CR54","doi-asserted-by":"crossref","first-page":"e000238","DOI":"10.1136\/openhrt-2015-000238","volume":"2","author":"SP Hoole","year":"2015","unstructured":"Hoole, S. P., Jaworski, C., Brown, A. J., McCormick, L. M., Agrawal, B., Clarke, S. C., et al. (2015). Serial assessment of the index of microcirculatory resistance during primary percutaneous coronary intervention comparing manual aspiration catheter thrombectomy with balloon angioplasty (IMPACT study): A randomised controlled pilot study. Open Heart., 2(1), e000238.","journal-title":"Open Heart."},{"issue":"8","key":"10062_CR55","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/MCA.0000000000000743","volume":"30","author":"Y Xiao","year":"2019","unstructured":"Xiao, Y., Fu, X., Wang, Y., Fan, Y., Wu, Y., Wang, W., et al. (2019). Effects of different strategies on high thrombus burden in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary catheterization. Coronary Artery Disease, 30(8), 555\u2013563.","journal-title":"Coronary Artery Disease"},{"issue":"S1","key":"10062_CR56","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/ccd.28112","volume":"93","author":"Y Fu","year":"2019","unstructured":"Fu, Y., Gu, X. S., Hao, G. Z., Jiang, Y. F., Fan, W. Z., Fan, Y. M., et al. (2019). Comparison of myocardial microcirculatory perfusion after catheter-administered intracoronary thrombolysis with anisodamine versus standard thrombus aspiration in patients with ST-elevation myocardial infarction. Catheterization and Cardiovascular Interventions, 93(S1), 839\u2013845.","journal-title":"Catheterization and Cardiovascular Interventions"},{"issue":"9","key":"10062_CR57","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jacc.2007.10.047","volume":"51","author":"H Kelbaek","year":"2008","unstructured":"Kelbaek, H., Terkelsen, C. J., Helqvist, S., Lassen, J. F., Clemmensen, P., Klovgaard, L., et al. (2008). Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: The drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial. Journal of the American College of Cardiology, 51(9), 899\u2013905.","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10062_CR58","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1253\/circj.CJ-10-0133","volume":"75","author":"N Ito","year":"2011","unstructured":"Ito, N., Nanto, S., Doi, Y., Kurozumi, Y., Tonomura, D., Natsukawa, T., et al. (2011). Distal protection during primary coronary intervention can preserve the index of microcirculatory resistance in patients with acute anterior ST-segment elevation myocardial infarction. Circulation Journal, 75(1), 94\u201398.","journal-title":"Circulation Journal"},{"issue":"8","key":"10062_CR59","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/hrt.2009.183277","volume":"96","author":"F Piscione","year":"2010","unstructured":"Piscione, F., Piccolo, R., Cassese, S., Galasso, G., D'Andrea, C., De Rosa, R., et al. (2010). Is direct stenting superior to stenting with predilation in patients treated with percutaneous coronary intervention? Results from a meta-analysis of 24 randomised controlled trials. Heart., 96(8), 588\u2013594.","journal-title":"Heart."},{"issue":"11","key":"10062_CR60","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jacc.2007.11.059","volume":"51","author":"T Cuisset","year":"2008","unstructured":"Cuisset, T., Hamilos, M., Melikian, N., Wyffels, E., Sarma, J., Sarno, G., et al. (2008). Direct stenting for stable angina pectoris is associated with reduced periprocedural microcirculatory injury compared with stenting after pre-dilation. Journal of the American College of Cardiology, 51(11), 1060\u20131065.","journal-title":"Journal of the American College of Cardiology"},{"issue":"18","key":"10062_CR61","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.jacc.2010.03.002","volume":"55","author":"HM Johnson","year":"2010","unstructured":"Johnson, H. M., Gossett, L. K., Piper, M. E., Aeschlimann, S. E., Korcarz, C. E., Baker, T. B., et al. (2010). Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. Journal of the American College of Cardiology, 55(18), 1988\u20131995.","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10062_CR62","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijcard.2007.05.019","volume":"128","author":"S Hosokawa","year":"2008","unstructured":"Hosokawa, S., Hiasa, Y., Miyazaki, S., Ogura, R., Miyajima, H., Ohara, Y., et al. (2008). Effects of smoking cessation on coronary endothelial function in patients with recent myocardial infarction. International Journal of Cardiology, 128(1), 48\u201352.","journal-title":"International Journal of Cardiology"},{"issue":"1","key":"10062_CR63","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1536\/ihj.14-189","volume":"56","author":"T Miyazaki","year":"2015","unstructured":"Miyazaki, T., Ashikaga, T., Ohigashi, H., Komura, M., Kobayashi, K., & Isobe, M. (2015). Impact of smoking on coronary microcirculatory resistance in patients with coronary artery disease. International Heart Journal, 56(1), 29\u201336.","journal-title":"International Heart Journal"},{"issue":"18","key":"10062_CR64","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1161\/01.CIR.0000164232.62768.51","volume":"111","author":"JO Prior","year":"2005","unstructured":"Prior, J. O., Quinones, M. J., Hernandez-Pampaloni, M., Facta, A. D., Schindler, T. H., Sayre, J. W., et al. (2005). Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus. Circulation., 111(18), 2291\u20132298.","journal-title":"Circulation."},{"issue":"10","key":"10062_CR65","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4244\/EIJY15M03_09","volume":"11","author":"M Leung","year":"2016","unstructured":"Leung, M., & Leung, D. Y. (2016). Coronary microvascular function in patients with type 2 diabetes mellitus. EuroIntervention., 11(10), 1111\u20131117.","journal-title":"EuroIntervention."},{"issue":"45","key":"10062_CR66","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/eurheartj\/ehv353","volume":"36","author":"GL De Maria","year":"2015","unstructured":"De Maria, G. L., Cuculi, F., Patel, N., Dawkins, S., Fahrni, G., Kassimis, G., et al. (2015). How does coronary stent implantation impact on the status of the microcirculation during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction? European Heart Journal, 36(45), 3165\u20133177.","journal-title":"European Heart Journal"},{"issue":"24","key":"10062_CR67","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","volume":"64","author":"EA Amsterdam","year":"2014","unstructured":"Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey Jr., D. E., Ganiats, T. G., Holmes Jr., D. R., et al. (2014). 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: A report of the American College of Cardiology\/American Heart Association task force on practice guidelines. Journal of the American College of Cardiology, 64(24), e139\u2013e228.","journal-title":"Journal of the American College of Cardiology"},{"issue":"11","key":"10062_CR68","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jacc.2014.05.064","volume":"64","author":"H Thiele","year":"2014","unstructured":"Thiele, H., de Waha, S., Zeymer, U., Desch, S., Scheller, B., Lauer, B., et al. (2014). Effect of aspiration thrombectomy on microvascular obstruction in NSTEMI patients: The TATORT-NSTEMI trial. Journal of the American College of Cardiology, 64(11), 1117\u20131124.","journal-title":"Journal of the American College of Cardiology"},{"issue":"23 Pt A","key":"10062_CR69","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/j.jacc.2018.09.006","volume":"72","author":"TJ Ford","year":"2018","unstructured":"Ford, T. J., Stanley, B., Good, R., Rocchiccioli, P., McEntegart, M., Watkins, S., et al. (2018). Stratified medical therapy using invasive coronary function testing in angina: The CorMicA Trial. Journal of American College of Cardiology, 72(23 Pt A), 2841\u20132855.","journal-title":"Journal of American College of Cardiology"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-020-10062-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-020-10062-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-020-10062-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T00:17:53Z","timestamp":1627085873000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-020-10062-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,24]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10062"],"URL":"https:\/\/doi.org\/10.1007\/s12265-020-10062-z","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,24]]},"assertion":[{"value":"23 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. James Xu has received minor research grants from Abbott. Dr. Sidney Lo has received minor research grants from Abbott. The other authors have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}